Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalba Minelli

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Biomedical Nanotechnology|June 16, 2016
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate CancerCasimiro Luca Gigliotti, Rosalba Minelli, Roberta Cavalli, et al.
Cancers|April 17, 2019
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung CancerJessica M Konen, B Leticia Rodriguez, Jared J Fradette, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2013
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cellsSergio Occhipinti, Chiara Dianzani, Annalisa Chiocchetti, et al.
The Biochemical Journal|June 3, 2026
Correction: Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with α-enolase devoid of plasminogen binding activityGiuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, et al.
The Biochemical Journal|June 11, 2009
Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activityFabrizio Gentile, Stefania Pizzimenti, Alessia Arcaro, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activityNicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
Free Radical Biology & Medicine|July 2, 2013
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma modelStefania Pizzimenti, Eric Ciamporcero, Piergiorgio Pettazzoni, et al.
Cancers|August 7, 2021
Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR PathwaysFederica Invrea, Simona Punzi, Consalvo Petti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2014
B7h triggering inhibits the migration of tumor cell linesChiara Dianzani, Rosalba Minelli, Casimiro Luca Gigliotti, et al.
JCI Insight|July 26, 2021
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancerAparna Padhye, Jessica M Konen, B Leticia Rodriguez, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Biomedical Nanotechnology|June 16, 2016
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate CancerCasimiro Luca Gigliotti, Rosalba Minelli, Roberta Cavalli, et al.
Cancers|April 17, 2019
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung CancerJessica M Konen, B Leticia Rodriguez, Jared J Fradette, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2013
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cellsSergio Occhipinti, Chiara Dianzani, Annalisa Chiocchetti, et al.
The Biochemical Journal|June 3, 2026
Correction: Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with α-enolase devoid of plasminogen binding activityGiuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, et al.
The Biochemical Journal|June 11, 2009
Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activityFabrizio Gentile, Stefania Pizzimenti, Alessia Arcaro, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activityNicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
Free Radical Biology & Medicine|July 2, 2013
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of β-cyclodextrin enhances the antitumoral efficacy of the aldehyde in several tumor cell lines and in a three-dimensional human melanoma modelStefania Pizzimenti, Eric Ciamporcero, Piergiorgio Pettazzoni, et al.
Cancers|August 7, 2021
Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR PathwaysFederica Invrea, Simona Punzi, Consalvo Petti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2014
B7h triggering inhibits the migration of tumor cell linesChiara Dianzani, Rosalba Minelli, Casimiro Luca Gigliotti, et al.
JCI Insight|July 26, 2021
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancerAparna Padhye, Jessica M Konen, B Leticia Rodriguez, et al.
Pageof 4